| Destination Education, Llc | |
|
503 Galina St, Beebe, AR 72012-3812 | |
| (501) 288-6549 | |
| (501) 232-5057 |
| Full Name | Destination Education, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 503 Galina St, Beebe, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013524180 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Destination Education, Llc 503 Galina St, Beebe, AR 72012-3812 Ph: (501) 288-6549 | Destination Education, Llc 503 Galina St, Beebe, AR 72012-3812 Ph: (501) 288-6549 |
News Archive
The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.
New research from the Centers for Disease Control & Prevention (CDC) suggest vaccines are highly protective against severe acute respiratory coronavirus 2 (SARS-CoV-2). Two doses of the Pfizer-BioNTech vaccine showed a 93% effectiveness against hospitalization. The findings add to a previous clinical trial that found vaccinated adolescents with 100% protection against SARS-CoV-2 infections.
Wisconsin Gov. Jim Doyle (D) has directed the state Department of Health and Family Services to notify federal officials that Wisconsin is refusing $600,000 in Title V federal abstinence education funds for fiscal year 2007, health department spokesperson Stephanie Marquis said on Friday, the Madison Capital Times reports.
Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade.
GenVec announced today that the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), has begun the second Phase 1 clinical trial in healthy adult volunteers of an HIV vaccine candidate jointly developed by the Dale and Betty Bumpers Vaccine Research Center (VRC), a part of NIAID, and GenVec.
› Verified 3 days ago
Monica Hofheinz, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Beebe, AR 72012 Phone: 501-882-5467 | |
Mrs. Jessica S Howard, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 242 Dugger Rd, Beebe, AR 72012 Phone: 501-288-6549 | |
Ann K Rushing, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Beebe, AR 72012 Phone: 501-882-3852 | |
Mrs. Mary Lynne Webb, MCD CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Center St, Beebe, AR 72012 Phone: 501-882-5463 | |
Mrs. Suzanne Hamilton Leslie, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Beebe, AR 72012 Phone: 501-882-8614 | |
Cynthia W Ireland, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1807 W Dewitt Henry Dr, Beebe, AR 72012 Phone: 501-882-7700 Fax: 501-882-7701 | |
Laeryn Nicole Ragsdale, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 N Main St, Beebe, AR 72012 Phone: 501-882-3852 Fax: 501-882-2759 |